Daiken Biomedical Co., Ltd. (TPE:7780)

Market Cap	15.88B +47.0%
Revenue (ttm)	1.90B +39.1%
Net Income	337.87M +217.0%
EPS	0.51 +110.0%
Shares Out	810.02M
PE Ratio	38.43
Forward PE	27.72
Dividend	0.40 (2.06%)
Ex-Dividend Date	Nov 24, 2025

Volume	2,213,285
Average Volume	5,507,133
Open	19.50
Previous Close	19.55
Day's Range	19.25 - 20.00
52-Week Range	14.65 - 40.10
Beta	n/a
RSI	34.87
Earnings Date	Apr 23, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. is a subsidiary of Sunfun Info Co., Ltd.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 7780

Financial Performance

In 2025, Daiken Biomedical's revenue was 1.90 billion, an increase of 39.10% compared to the previous year's 1.36 billion. Earnings were 337.87 million, an increase of 217.01%.